Cargando…

Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer

Pentatricopeptide repeat domain protein 3 (PTCD3) is a mitochondrial RNA-binding protein that serves a role in mitochondrial translation. PTCD3 was originally reported as an oncogene that is involved in breast cancer and lymphoma. However, the expression and function of PTCD3 in prostate cancer (PCa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yiqiao, Jiang, Ganggang, Liang, Xue, Lan, Ziquan, Su, Zhengming, Wu, Hualing, Weng, Jinsheng, Jiang, Xianhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131642/ https://www.ncbi.nlm.nih.gov/pubmed/30132530 http://dx.doi.org/10.3892/mmr.2018.9402

Ejemplares similares

Molecular and cellular mechanisms of castration resistant prostate cancer
por: Huang, Yiqiao, et al.
Publicado: (2018)

p62 promotes proliferation, apoptosis-resistance and invasion of prostate cancer cells through the Keap1/Nrf2/ARE axis
por: Jiang, Ganggang, et al.
Publicado: (2020)

Downregulation of PTCD1 in Bladder Urothelial Carcinoma Predicts Poor Prognosis and Levels of Immune Infiltration
por: Zhou, Zhongbao, et al.
Publicado: (2022)

Study of preserving the PTCD tube after laparoscopic pancreaticoduodenectomy
por: Wu, Haojun, et al.
Publicado: (2023)

Leigh syndrome is the main clinical characteristic of PTCD3 deficiency
por: Muñoz‐Pujol, Gerard, et al.
Publicado: (2022)

Targeting cancers through TCR-peptide/MHC interactions
por: He, Qinghua, et al.
Publicado: (2019)

A Novel Circular RNA circPTCD3 Promotes Breast Cancer Progression Through Sponging miR-198
por: Zhang, Zhaohui, et al.
Publicado: (2021)

Revision of the common bile duct in a combined PTCD/ERC approach – A case report
por: Kleinwort, A., et al.
Publicado: (2021)

Pentatricopeptide Protein PTCD2 Regulates COIII Translation in Mitochondria of the HeLa Cell Line
por: Baleva, Maria V., et al.
Publicado: (2022)

MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma
por: Su, Zhengming, et al.
Publicado: (2020)

Elevated HABP1 protein expression correlates with progression and poor survival in patients with gastric cancer
por: Gao, Hongyu, et al.
Publicado: (2016)

Analysis of the Bacterial Spectrum and Key Clinical Factors of Biliary Tract Infection in Patients with Malignant Obstructive Jaundice after PTCD
por: Xing, Dongjuan, et al.
Publicado: (2022)

Functional Differences of Grapevine Circular RNA Vv-circPTCD1 in Arabidopsis and Grapevine Callus under Abiotic Stress
por: Ren, Yi, et al.
Publicado: (2023)

Elevated p53 expression levels correlate with tumor progression and poor prognosis in patients exhibiting esophageal squamous cell carcinoma
por: HUANG, KATE, et al.
Publicado: (2014)

Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer
por: Sun, Jian, et al.
Publicado: (2022)

Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression
por: Liao, Wen-Ting, et al.
Publicado: (2009)

Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer
por: Jin, Chuan, et al.
Publicado: (2017)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
por: Lei, Fangyong, et al.
Publicado: (2014)

Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer
por: Zhao, Tianyi, et al.
Publicado: (2021)

Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement
por: Dong, Weimin, et al.
Publicado: (2022)

Elevated expression of CXCL16 correlates with poor prognosis in patients with colorectal cancer
por: Chen, Zhihui, et al.
Publicado: (2019)

Elevated Small Nuclear Ribonucleoprotein Polypeptide an Expression Correlated With Poor Prognosis and Immune Infiltrates in Patients With Hepatocellular Carcinoma
por: Zhang, Youfu, et al.
Publicado: (2022)

Decreased P27 protein expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma
por: Jiang, Qingping, et al.
Publicado: (2013)

Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer
por: Zhang, Yixiang, et al.
Publicado: (2017)

Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients
por: Deng, Haifeng, et al.
Publicado: (2019)

The Upregulation of GSTO2 is Associated with Colon Cancer Progression and a Poor Prognosis
por: Peng, Xingyu, et al.
Publicado: (2023)

Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis
por: Dai, Da-nian, et al.
Publicado: (2017)

Elevated MRE11 expression associated with progression and poor outcome in prostate cancer
por: Wang, Jun, et al.
Publicado: (2019)

Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2021)

High Nuclear Expression of HDGF Correlates with Disease Progression and Poor Prognosis in Human Endometrial Carcinoma
por: Wang, Lijing, et al.
Publicado: (2014)

High expression of PDE4D correlates with poor prognosis and clinical progression in pancreaticductal adenocarcinoma
por: Liu, Fude, et al.
Publicado: (2019)

Elevated expression of chloride intracellular channel 1 is correlated with poor prognosis in human gliomas
por: Wang, Liang, et al.
Publicado: (2012)

Elevated NDC1 expression predicts poor prognosis and correlates with immunity in hepatocellular carcinoma
por: Liu, Qingqing, et al.
Publicado: (2023)

AB079. Upregulation of DEPDC1B correlates with tumor progression and predicts a poor prognosis in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2017)

Elevated mean platelet volume predicts poor prognosis in colorectal cancer
por: Li, Na, et al.
Publicado: (2017)

Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer
por: Wang, Jia-Hong, et al.
Publicado: (2017)

Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis
por: Lan, Xiuwen, et al.
Publicado: (2017)

Elevated Expression of Glycerol-3-Phosphate Phosphatase as a Biomarker of Poor Prognosis and Aggressive Prostate Cancer
por: Lounis, Mohamed Amine, et al.
Publicado: (2021)

Elevated expression of Tiam1 is associated with poor prognosis and promotes tumor progression in pancreatic cancer
por: Ding, Mina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_572f0582c33i8jcdb1tanjt9uo